Skanska USA Building Inc. v. Regeneron Pharmaceuticals Inc.
Opinion
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK SKANSKA USA BUILDING INC., Plaintiff, ORDER -against- 23-CV-08418(PMH) REGENERON PHARMACEUTICALS INC., and SHAWN’S LAWNS INC., Defendants.
PHILIP M. HALPERN, United States District Judge: A pre-motion conference was held on November 25, 2024, concerning Defendant Regeneron’s anticipated motion to strike paragraphs 195-211 and 304-305 in the First Amended Complaint (the “Disputed Allegations”) pursuant to Federal Rule of Civil Procedure 12(f). Counsel for all parties appeared. The Court construed Defendant Regeneron’s pre-motion letter (Doc. 61) as its motion to strike, Plaintiff's response letter (Doc. 60) as its opposition, and considering the parties’ arguments made in their joint letter (Doc. 75) and at the conference, granted the motion to strike. (See Transcript); see Jn re Best Payphones, Inc., 450 F. App’x 8, 15 (2d Cir. 2011) (finding the Court did not abuse its discretion in construing the parties’ letter-motions as the motions themselves, and ruling on them). Plaintiff shall, by December 2, 2024, file a Second Amended Complaint which only eliminates the Disputed Allegations. Defendants Regeneron and Shawn’s Lawns Inc. shall, by December 9, 2024, each file an amended answer which only eliminates their responses to the Disputed Allegations. SO ORDERED: Dated: White Plains, New York November 25, 2024 Goamu/ Philip M. Halpern” United States District Judge
Free access — add to your briefcase to read the full text and ask questions with AI
Skanska USA Building Inc. v. Regeneron Pharmaceuticals Inc. (Skanska USA Building Inc. v. Regeneron Pharmaceuticals Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.